explore -WSS

explore

author：explore 2025-10-02 20:52:24 - browse：34

Nathan Guo, left, and his wife Ada Lio encourage their 17-month-old son, Lucas Guo, to take steps in his gate trainer at their home in Somerville, MA on February 16, 2024. Lucas has one of the world's rarest diseases, ZTTK Syndrome — Lucas Guo, a boy with a rare neurological condition called ZTTK, is encouraged by his father, Nathan Guo, and mother, Ada Lio, to take some steps. Craig F. Walker/The Boston Globe

SOMERVILLE — At 19 months old, Lucas Guo has never crawled, walked, or stood by himself. He babbles but can’t say words. He struggles to chew and swallow. He gets most of his nutrition through a feeding tube attached to his belly.

Lucas has one of the world’s rarest diseases, ZTTK syndrome, a complex neurological disorder caused by a genetic mutation. Scientists have documented only about 60 cases worldwide and estimate that, at most, it afflicts several hundred people — far too few to encourage drug makers to find a treatment.

That economic reality has driven Lucas’s parents, Ada Lio and Nathan Guo, to take things into their own hands. Working through a small foundation, they are trying to raise $10 million to develop a treatment or cure for ZTTK in five years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Study suggests new cause of Down syndrome: cells linked to aging

WSS

Medicare Advantage coverage denials need scrutiny, senators say

Readout LOUD podcast: Merger Mondays, Ozempic panic

Fauci's latest grilling in Congress: 9 hours, behind closed doors

There’s no way to know how good AI health technologies are

STAT Readout Newsletter: Today in biotech, life science news

In shift, Texas to cover initial consult for Afghan baby's gene therapy

knowledge

explore

hotspot

The cancer drug shortage isn’t new — and neither are the solutions

Arena BioWorks launches in Cambridge to speed drug discovery

Medicare details structure of new drug price negotiation program

European regulators recommend Amylyx's ALS drug be rejected

DIEP, the 'gold standard' of breast reconstruction, is under threat

STAT Readout: Today's biotech news includes Sana and Amylyx

In Memoriam: Notable people who died in 2023

How doctors and nurses shape Google's AI

Virginia high school admissions case could be legal follow

Eight reasons why you should get an updated Covid vaccine

Wikipedia

Peter Marks talks Operation Warp Speed for Rare Diseases

Medicare to cover more brain scans related to Alzheimer’s drugs

Hospital chaplains balance Covid safety with patients’ spiritual needs

Better Therapeutics data on benefit with GLP

A revolution in caring for preterm infants

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

hotspot

focus

focus

entertainment